Document Detail

Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
MedLine Citation:
PMID:  23018875     Owner:  NLM     Status:  Publisher    
Although tumor budding is linked to adverse prognosis in colorectal cancer, it remains largely unreported in daily diagnostic work due to the absence of a standardized scoring method. Our aim was to assess the inter-observer agreement of a novel 10-high-power-fields method for assessment of tumor budding at the invasive front and to confirm the prognostic value of tumor budding in our setting of colorectal cancers. Whole tissue sections of 215 colorectal cancers with full clinico-pathological and follow-up information were stained with cytokeratin AE1/AE3 antibody. Presence of buds was scored across 10-high-power fields at the invasive front by two pathologists and two additional observers were asked to score 50 cases of tumor budding randomly selected from the larger cohort. The measurements were correlated to the patient and tumor characteristics. Inter-observer agreement and correlation between observers' scores were excellent (P<0.0001; intraclass correlation coefficient=0.96). A test subgroup of 65 patients (30%) was used to define a valid cutoff score for high-grade tumor budding and the remaining 70% of the patients were entered into the analysis. High-grade budding was defined as an average of ≥10 buds across 10-high-power fields. High-grade budding was associated with a higher tumor grade (P<0.0001), higher TNM stage (P=0.0003), vascular invasion (P<0.0001), infiltrating tumor border configuration (P<0.0001) and reduced survival (P<0.0001). Multivariate analysis confirmed its independent prognostic effect (P=0.007) when adjusting for TNM stage and adjuvant therapy. Using 10-high-power fields for evaluating tumor budding has independent prognostic value and shows excellent inter-observer agreement. Like the BRE and Gleason scores in breast and prostate cancers, respectively, tumor budding could be a basis for a prognostic score in colorectal cancer.Modern Pathology advance online publication, 28 September 2012; doi:10.1038/modpathol.2012.155.
Eva Karamitopoulou; Inti Zlobec; Viktor Kölzer; Agathi Kondi-Pafiti; Efstratios S Patsouris; Konstantin Gennatas; Alessandro Lugli
Related Documents :
12120675 - Acquired ear defects.
24921635 - Risk of secondary malignancy (including breast) in patients with mismatch-repair protei...
3390075 - Diseases of the intrapetrous carotid artery.
21557355 - Molecular editing and assessment of the cytotoxic properties of iejimalide and progeny.
15791575 - Glomus tumor of renal pelvis: a case report and review of the literature.
16670195 - Caspase-3, tunel and ultrastructural studies of small follicles in adult human ovarian ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-28
Journal Detail:
Title:  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc     Volume:  -     ISSN:  1530-0285     ISO Abbreviation:  Mod. Pathol.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806605     Medline TA:  Mod Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1] Institute of Pathology, University of Bern, Bern, Switzerland [2] 1st Department of Pathology, University of Athens, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with hig...
Next Document:  Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of ...